These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
322 related articles for article (PubMed ID: 38255281)
1. Innovative Biomedical and Technological Strategies for the Control of Bacterial Growth and Infections. Matias LLR; Damasceno KSFDSC; Pereira AS; Passos TS; Morais AHA Biomedicines; 2024 Jan; 12(1):. PubMed ID: 38255281 [TBL] [Abstract][Full Text] [Related]
2. Antibiotic resistant bacteria: current situation and treatment options to accelerate the development of a new antimicrobial arsenal. Tarín-Pelló A; Suay-García B; Pérez-Gracia MT Expert Rev Anti Infect Ther; 2022 Aug; 20(8):1095-1108. PubMed ID: 35576494 [TBL] [Abstract][Full Text] [Related]
3. [Development of antituberculous drugs: current status and future prospects]. Tomioka H; Namba K Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921 [TBL] [Abstract][Full Text] [Related]
4. Leveraging Marine Natural Products as a Platform to Tackle Bacterial Resistance and Persistence. Valdes-Pena MA; Massaro NP; Lin YC; Pierce JG Acc Chem Res; 2021 Apr; 54(8):1866-1877. PubMed ID: 33733746 [TBL] [Abstract][Full Text] [Related]
5. Design and Synthesis of Novel Antimicrobial Agents. Breijyeh Z; Karaman R Antibiotics (Basel); 2023 Mar; 12(3):. PubMed ID: 36978495 [TBL] [Abstract][Full Text] [Related]
6. Three Innovations of Next-Generation Antibiotics: Evolvability, Specificity, and Non-Immunogenicity. Shim H Antibiotics (Basel); 2023 Jan; 12(2):. PubMed ID: 36830114 [TBL] [Abstract][Full Text] [Related]
7. Bacterial genome engineering and synthetic biology: combating pathogens. Krishnamurthy M; Moore RT; Rajamani S; Panchal RG BMC Microbiol; 2016 Nov; 16(1):258. PubMed ID: 27814687 [TBL] [Abstract][Full Text] [Related]
8. Bacterial Resistance: Antibiotics of Last Generation used in Clinical Practice and the Arise of Natural Products as New Therapeutic Alternatives. Corrêa RCG; Heleno SA; Alves MJ; Ferreira ICFR Curr Pharm Des; 2020; 26(8):815-837. PubMed ID: 32091328 [TBL] [Abstract][Full Text] [Related]
9. Thymol-Decorated Gold Nanoparticles for Curing Clinical Infections Caused by Bacteria Resistant to Last-Resort Antibiotics. Huang Z; Zhang X; Yao Z; Han Y; Ye J; Zhang Y; Chen L; Shen M; Zhou T mSphere; 2023 Jun; 8(3):e0054922. PubMed ID: 37017551 [TBL] [Abstract][Full Text] [Related]
10. Antibiotic resistance: The challenges and some emerging strategies for tackling a global menace. Chinemerem Nwobodo D; Ugwu MC; Oliseloke Anie C; Al-Ouqaili MTS; Chinedu Ikem J; Victor Chigozie U; Saki M J Clin Lab Anal; 2022 Sep; 36(9):e24655. PubMed ID: 35949048 [TBL] [Abstract][Full Text] [Related]
11. Mechanistic Understanding Enables the Rational Design of Salicylanilide Combination Therapies for Gram-Negative Infections. Copp JN; Pletzer D; Brown AS; Van der Heijden J; Miton CM; Edgar RJ; Rich MH; Little RF; Williams EM; Hancock REW; Tokuriki N; Ackerley DF mBio; 2020 Sep; 11(5):. PubMed ID: 32934086 [TBL] [Abstract][Full Text] [Related]
12. Harnessing Rare Actinomycete Interactions and Intrinsic Antimicrobial Resistance Enables Discovery of an Unusual Metabolic Inhibitor. McClung DJ; Du Y; Antonich DJ; Bonet B; Zhang W; Traxler MF mBio; 2022 Jun; 13(3):e0039322. PubMed ID: 35608300 [TBL] [Abstract][Full Text] [Related]
13. Returning to Nature for the Next Generation of Antimicrobial Therapeutics. MacNair CR; Tsai CN; Rutherford ST; Tan MW Antibiotics (Basel); 2023 Aug; 12(8):. PubMed ID: 37627687 [TBL] [Abstract][Full Text] [Related]
14. Antibiotic resistance in microbes: History, mechanisms, therapeutic strategies and future prospects. Uddin TM; Chakraborty AJ; Khusro A; Zidan BRM; Mitra S; Emran TB; Dhama K; Ripon MKH; Gajdács M; Sahibzada MUK; Hossain MJ; Koirala N J Infect Public Health; 2021 Dec; 14(12):1750-1766. PubMed ID: 34756812 [TBL] [Abstract][Full Text] [Related]